# Evaluation of the Concentration of ANT3310 and Meropenem in the Lung in Healthy Adult Participants

> **NCT06916156** · PHASE1 · COMPLETED · sponsor: **Antabio** · enrollment: 26 (actual)

## Conditions studied

- Pharmacokinetics Study on Healthy Volunteers Adults

## Interventions

- **DRUG:** ANT3310
- **DRUG:** Meropenem

## Key facts

- **NCT ID:** NCT06916156
- **Lead sponsor:** Antabio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-04-28
- **Primary completion:** 2025-08-14
- **Final completion:** 2025-08-19
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2025-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06916156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06916156, "Evaluation of the Concentration of ANT3310 and Meropenem in the Lung in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06916156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*